VALEANT PHARMACEUTICALS INTERNATIONAL
CIK 0000930184
Revenue (TTM)
—
Q2 Jul 2010
Net Income (TTM)
—
Q2 Jul 2010
EPS Diluted (TTM)
—
Q2 Jul 2010
Gross Margin
—
Q2 Jul 2010
Operating Margin
—
Q2 Jul 2010
Net Margin
—
Q2 Jul 2010
Free Cash Flow (TTM)
—
Q2 Jul 2010
Cash
$75.38M
Q2 Jul 2010
Total Debt
$82.28M
Q2 Jul 2010
Shares Outstanding
75.92M sh
Q2 Jul 2010